Skip to main content
. 2022 Nov 20;14(11):2527. doi: 10.3390/pharmaceutics14112527

Table 1.

The composition and characterization parameters of different SLNs formulations.

Formulation Code Lipid Type Lipid to QCT Ratio Stabilizer Type Stabilizer Concentration
(%w/v)
PS (nm) PDI ZP (mV) EE (%) DL (%)
Pr-QCT-SLNs-1 Precirol 15:1 Tween 80 1.25 182 ± 3 0.33 ± 0.01 - 65 ± 1.2 -
Pr-QCT-SLNs-2 Precirol 15:1 Tween 80 2.5 131 ± 2 0.27 ± 0.02 - 60.3 ± 1 -
Pr-QCT-SLNs-3 Precirol 15:1 Tween 80 5 114 ± 2 0.22 ± 0.01 - 45.6 ± 1.5 -
Pr-QCT-SLNs-4 Precirol 30:1 P188 0.1 691 ± 14 0.38 ± 0.07 - 98.2 ± 0.6 -
Pr-QCT-SLNs-5 Precirol 30:1 P188 0.5 341 ± 3 0.18 ± 0.01 - 98.4 ± 0.6 -
Pr-QCT-SLNs-6 Precirol 30:1 P188 0.75 364 ± 9 0.25 ± 0.01 - 98.8 ± 0.8 -
Pr-QCT-SLNs-7 Precirol 5:1 P188 0.5 346 ± 21 0.46 ± 0.04 - 98.6 ± 1 19.2 ± 1
Pr-QCT-SLNs-8 Precirol 10:1 P188 0.5 220 ± 2 0.32 ± 0.02 −33 ± 7 99 ± 1.1 8 ± 0.5
Pr-QCT-SLNs-9 Precirol 15:1 P188 0.5 304 ± 1 0.33 ± 0.02 - 98.4 ± 0.7 5.5 ± 0.4
Pr-SLNs-8 Precirol 10:1 P188 0.5 264 ± 4 0.25 ± 0.02 - - -
C-Pr-QCT-SLNs-8 Precirol 10:1 P188 0.5 243 ± 3 0.33 ± 0.03 20 ± 4 98.4 ± 1 6.7 ± 0.4
St-QCT-SLNs-1 Stearic acid 5:1 P188 0.5 323 ± 7 0.32 ± 0.03 - 98 ± 0.7 18.1 ± 1.1
St-QCT-SLNs-2 Stearic acid 10:1 P188 0.5 262 ± 7 0.23 ± 0.01 −34 ± 7 98.3 ± 1.5 8.87 ± 0.3
St-QCT-SLNs-3 Stearic acid 15:1 P188 0.5 359 ± 7 0.19 ± 0.02 −37 ± 7 98 ± 1 6.27 ± 0.1
St-SLNs-2 Stearic acid 10:1 P188 0.5 240 ± 5 0.13 ± 0.03 - - -
C-St-QCT-SLNs-2 Stearic acid 10:1 P188 0.5 275 ± 3 0.21 ± 0.02 29 ± 6 99 ± 1.2 8.85 ± 0.6

Results are presented as mean ± standard deviation (n = 3). Abbreviations: PS: particle size, PDI: polydispersity index, ZP: zeta potential, EE: entrapment efficiency, DL: drug loading, P188: poloxamer 188, QCT: quercetin, Pr: precirol, St: stearic acid, C: coated, SLNs: solid lipid nanoparticles.